» Articles » PMID: 35456794

Harnessing the Algal Chloroplast for Heterologous Protein Production

Overview
Journal Microorganisms
Specialty Microbiology
Date 2022 Apr 23
PMID 35456794
Authors
Affiliations
Soon will be listed here.
Abstract

Photosynthetic microbes are gaining increasing attention as heterologous hosts for the light-driven, low-cost production of high-value recombinant proteins. Recent advances in the manipulation of unicellular algal genomes offer the opportunity to establish engineered strains as safe and viable alternatives to conventional heterotrophic expression systems, including for their use in the feed, food, and biopharmaceutical industries. Due to the relatively small size of their genomes, algal chloroplasts are excellent targets for synthetic biology approaches, and are convenient subcellular sites for the compartmentalized accumulation and storage of products. Different classes of recombinant proteins, including enzymes and peptides with therapeutical applications, have been successfully expressed in the plastid of the model organism , and of a few other species, highlighting the emerging potential of transplastomic algal biotechnology. In this review, we provide a unified view on the state-of-the-art tools that are available to introduce protein-encoding transgenes in microalgal plastids, and discuss the main (bio)technological bottlenecks that still need to be addressed to develop robust and sustainable green cell biofactories.

Citing Articles

Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation.

Cutolo E, Campitiello R, Di Dato V, Orefice I, Angstenberger M, Cutolo M Mar Drugs. 2025; 23(2).

PMID: 39997210 PMC: 11857744. DOI: 10.3390/md23020086.


The First Introduction of an Exogenous 5' Untranslated Region for Control of Plastid Transgene Expression in Chlamydomonas reinhardtii.

Abbasi-Vineh M, Emadpour M Mol Biotechnol. 2024; .

PMID: 39271617 DOI: 10.1007/s12033-024-01279-3.


Immunomodulatory Compounds from the Sea: From the Origins to a Modern Marine Pharmacopoeia.

Cutolo E, Campitiello R, Caferri R, Pagliuca V, Li J, Agathos S Mar Drugs. 2024; 22(7).

PMID: 39057413 PMC: 11278107. DOI: 10.3390/md22070304.


Harnessing the potential of microalgae for the production of monoclonal antibodies and other recombinant proteins.

Rajput B, Ikram S, Tripathi B Protoplasma. 2024; 261(6):1105-1125.

PMID: 38970700 DOI: 10.1007/s00709-024-01967-6.


Pharmaceutical removal from wastewater by introducing cytochrome P450s into microalgae.

Kariyawasam T, Helvig C, Petkovich M, Vriens B Microb Biotechnol. 2024; 17(6):e14515.

PMID: 38925623 PMC: 11197475. DOI: 10.1111/1751-7915.14515.


References
1.
Rott R, Liveanu V, Drager R, Stern D, Schuster G . The sequence and structure of the 3'-untranslated regions of chloroplast transcripts are important determinants of mRNA accumulation and stability. Plant Mol Biol. 1998; 36(2):307-14. DOI: 10.1023/a:1005943701253. View

2.
Braun-Galleani S, Baganz F, Purton S . Improving recombinant protein production in the Chlamydomonas reinhardtii chloroplast using vivid Verde Fluorescent Protein as a reporter. Biotechnol J. 2015; 10(8):1289-97. PMC: 4985702. DOI: 10.1002/biot.201400566. View

3.
Patra K, Li F, Carter D, Gregory J, Baga S, Reed S . Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes. Infect Immun. 2015; 83(5):1799-808. PMC: 4399074. DOI: 10.1128/IAI.02980-14. View

4.
Jakubiec A, Sarokina A, Choinard S, Vlad F, Malcuit I, Sorokin A . Replicating minichromosomes as a new tool for plastid genome engineering. Nat Plants. 2021; 7(7):932-941. DOI: 10.1038/s41477-021-00940-y. View

5.
Suay L, Salvador M, Abesha E, Klein U . Specific roles of 5' RNA secondary structures in stabilizing transcripts in chloroplasts. Nucleic Acids Res. 2005; 33(15):4754-61. PMC: 1188514. DOI: 10.1093/nar/gki760. View